NDRAW
Income statement / Annual
Last year (2021), ENDRA Life Sciences Inc. Warrants's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2021, ENDRA Life Sciences Inc. Warrants's net income was -$11.35 M.
See ENDRA Life Sciences Inc. Warrants,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$6,174.00
|
$351,622.00
|
$515,582.00
|
$1.41 M
|
$559,355.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$172,782.00 |
$235,878.00 |
$666,233.00 |
$259,145.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$6,174.00 |
$178,840.00 |
$279,704.00 |
$743,831.00 |
$300,210.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
1 |
0.51 |
0.54 |
0.53 |
0.54 |
| Research and Development
Expenses |
$5.48 M
|
$5.92 M
|
$6.57 M
|
$4.72 M
|
$1.93 M
|
$495,377.00
|
$1.04 M
|
$873,167.00
|
| General & Administrative
Expenses |
$4.94 M
|
$4.42 M
|
$3.44 M
|
$3.49 M
|
$2.63 M
|
$1.54 M
|
$1.22 M
|
$896,926.00
|
| Selling & Marketing
Expenses |
$1.08 M
|
$581,893.00
|
$412,434.00
|
$262,641.00
|
$122,604.00
|
$34,130.00
|
$50,635.00
|
$56,298.00
|
| Selling, General &
Administrative Expenses |
$6.02 M
|
$5.00 M
|
$3.86 M
|
$3.75 M
|
$2.75 M
|
$1.58 M
|
$1.27 M
|
$953,224.00
|
| Other Expenses |
$0.00 |
$581,893.00 |
$412,434.00 |
$550,182.00 |
$122,604.00 |
-$1.00 |
$1.00 |
$0.00 |
| Operating Expenses |
$11.50 M |
$11.50 M |
$10.84 M |
$9.03 M |
$4.80 M |
$2.07 M |
$2.31 M |
$1.83 M |
| Cost And Expenses |
$11.50 M |
$11.50 M |
$10.84 M |
$9.03 M |
$4.98 M |
$2.31 M |
$2.98 M |
$2.09 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$232,426.00 |
$2.36 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$224,415.00
|
$99,342.00
|
$2.47 M
|
$797,557.00
|
$772,953.00
|
$64,936.00
|
$72,225.00
|
$37,242.00
|
| EBITDA |
-$11.01 M
|
-$11.39 M
|
-$12.70 M
|
-$9.00 M
|
-$4.60 M
|
-$2.71 M
|
-$2.21 M
|
-$2.14 M
|
| EBITDA Ratio |
0 |
0 |
0 |
-1457.52 |
-13.09 |
-5.26 |
-1.57 |
-3.83 |
| Operating Income Ratio
|
0
|
0
|
0
|
-1460.8
|
-13.16
|
-3.48
|
-1.11
|
-2.73
|
| Total Other
Income/Expenses Net |
$0.00
|
-$223,584.00
|
-$2.46 M
|
-$777,253.00
|
-$750,904.00
|
-$983,610.00
|
-$710,633.00
|
-$654,697.00
|
| Income Before Tax |
-$11.23 M |
-$11.73 M |
-$13.31 M |
-$9.80 M |
-$5.38 M |
-$2.78 M |
-$2.28 M |
-$2.18 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
-1586.7
|
-15.29
|
-5.38
|
-1.62
|
-3.9
|
| Income Tax Expense |
$121,071.00 |
$8,842.00 |
-$106,903.00 |
-$777,253.00 |
-$750,904.00 |
-$983,610.00 |
-$710,633.00 |
-$654,697.00 |
| Net Income |
-$11.35 M |
-$11.73 M |
-$17.53 M |
-$9.80 M |
-$5.38 M |
-$2.78 M |
-$2.28 M |
-$2.18 M |
| Net Income Ratio |
0 |
0 |
0 |
-1586.7 |
-15.29 |
-5.38 |
-1.62 |
-3.9 |
| EPS |
-0.82 |
-0.85 |
-2.34 |
-2.17 |
-1.95 |
-1.01 |
-0.83 |
-0.79 |
| EPS Diluted |
-0.82 |
-0.85 |
-2.34 |
-2.17 |
-1.95 |
-1.01 |
-0.83 |
-0.79 |
| Weighted Average Shares
Out |
$13.80 M
|
$13.80 M
|
$7.50 M
|
$4.50 M
|
$2.76 M
|
$2.76 M
|
$2.76 M
|
$2.76 M
|
| Weighted Average Shares
Out Diluted |
$13.80 M
|
$13.80 M
|
$7.50 M
|
$4.50 M
|
$2.76 M
|
$2.76 M
|
$2.76 M
|
$2.76 M
|
| Link |
|
|
|
|
|
|
|
|
